Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC]

Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC] was reported 0 times

These side effects are most commonly reported by patients taking drugs of the Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC] class:

# Drug class Count